The startup world is changing! Startups in “hard sciences” like biology or chemistry are now getting the attention they deserve from big investors and Fortune 500 companies.
PMWC 2018 Company Showcases
This is an exciting time to work in the fast-paced, innovative world of startups. Inventive approaches that challenge the traditional path to drug discovery, clinical trial patient selection, diagnostics, biomarker identification, disease understanding, big data analysis, instruments development, and more are truly disrupting healthcare.
At the upcoming PMWC 2018 Silicon Valley conference, January 22-24, 2018, we are adding a 5th Track for the first time in order to accommodate THREE dedicated tracks showcasing these innovative companies. You’ll hear their impressive stories, including their most recent developments and see how they’re changing healthcare to achieve better outcomes, reduce costs, expedite disease identification, improve patient treatment and prevent disease.
150+ up and coming companies working in Artificial Intelligence, Immunotherapy, Liquid Biopsy, Data Applications in Clinical Dx, NGS Data, CRISPR and the Microbiome will be presenting. Find the growing list at the end of this email and in the program. In addition, we’ll feature a session on the challenges and opportunities of Blockchain in Precision Medicine.
PMWC 2018 Company Competition
In addition to the three Company Showcase tracks, we provide the Company Competition as an opportunity for emerging companies to be spotlighted and noticed by VCs.
Past winners in the Company Competition span a wide variety of platforms and applications including diagnostics, genome editing, NI IVF test, Rx/Dx development, and digital PCR.
Submit your own company to get the opportunity to present or nominate another promising early-stage company to participate in this prestigious competition and vie for the top award. This event guarantees the much coveted exposure and recognition required to reach the next level.
Exhibit
PMWC 2018 Silicon Valley offers exhibition opportunities for emerging and established companies and organizations to showcase their products and services to PMWC participants who are actively involved in and leading the personalized medicine revolution. See who is exhibiting here. If you are interested in exhibiting this year, contact us today as we are 90% booked.
List of Showcase Companies and Company Competition Contestants:
Artificial Intelligence
- AiCure (Adam Hanina)
- All4Cure (Tony Blau)
- Altoida (Ioannis Tarnanas)
- Arterys (Fabien Beckers)
- Atomwise (Abraham Heifets)
- Ayasdi (Bob Griffin)
- Bay Labs (Charles Cadieu)
- Berg Analytics (Slava Akmaev)
- Biodesix (Heinrich Roder)
- Carta Healthcare (David Scheinker)
- Cofactor Genomics (Jarret Glasscock)
- Cognoa (Sharief Taraman)
- CureMetrix (Kevin Harris)
- Data Collective (Scott Barclay)
- doc.ai (Walter De Brouwer)
- DxTerity (Bob Terbrueggen)
- e-Therapeutics (Jonny Wray)
- Exscientia (Andrew Hopkins)
- Freenome (Gabe Otte)
- GNS Healthcare (Diane Wuest)
- Good AI Lab (Mohsen Hejrati)
- Healx (Tim Guilliams)
- InnVentis (Thomas Wilckens)
- Insilico Medicine (Alex Zhavoronkov)
- Lumiata (Ash Damle)
- Lunit (Anthony Paek)
- Mediimsight (Javier Gonzalez-Zabaleta)
- Mendel.ai (Karim Galil)
- Molecular Health
- NuMedii (Asim Siddiqui)
- Numerate (Guido Lanza)
- Oxford University
- Owkin (Thomas Clozel)
- PathAi (Andrew Beck)
- Pathway Genomics (Michael Nova)
- PhenoMX (Mark Punyanitya)
- Physiq (Gary Conkright)
- quibim (Angel Alberich-Bayarri)
- Recursion Pharma (Ron Alfa)
- Sema4 (Eric Schadt)
- SkinVision (Erik de Heus)
- Sophia Genetics (Jurgi Camblong)
- SRI (David Sahner)
- Standigm (Sang Ok Song)
- Suggestic (Victor Chapela)
- Tempus (Eric Lefkofsky)
- twoXAR (Andrew Radin)
- UCSF (John Shephard)
- USC (Dan Ruderman)
- Verily (Jessica Mega)
- Zogenix (Anupam Agarwal)
Immunotherapy
- Abpro (Gavin MacBeath)
- Adaptimmune (Rafael Amado)
- Adicet Bio (Aya Jackovits)
- Bavarian Nordic (Christopher Heery)
- BeiGene (Amy Peterson)
- CellSight Technology (Aruna Gambhir)
- Compugen (John Hunter)
- Five Prime (Rusty Williams)
- Genentech (Ira Mellman)
- Genocea Biosciences (Jessica Baker Flechtner)
- Gristone Oncology (Roman Yelensky)
- Heat Biologics (Jeffrey Hutchins)
- Idera Pharmaceuticals (Joanna Horobin)
- Immix (Ilya Michael Rachman)
- Immune Design (Sergey Yurasov)
- Immune Systems Key (Yoram Devary)
- ImmunGene (Michael Gresser)
- Imperial College (Justin Stebbing)
- Incyte (Susan Snodgrass)
- MacroGenics (Jon Wigginton)
- Massachusetts General Hospital (Mark Cobbold)
- Medigene AG (Dolores Schendel)
- Mitra Biotech (Parker Cassidy)
- NanoString (Alessandra Cesano)
- NantKwest (David Pyrce)
- Neon (Richard Gaynor)
- Olink Proteomics (Jon Heimer)
- Onco Response (Kristine Swiderek)
- Oncorus (Mitchell Finer)
- Parker Inst. (Jeff Bluestone)
- Precision Oncology (Patricia Devitt Risse)
- Stanford Healthcare (Ron Levy)
- UCSC (Daniel Kim)
- Xcell Biosciences (Brian Feth)
Liquid Biopsy, Data App in Clinical Dx & NGS Data
- Accuragen (Li Weng)
- Angle PLC
- Ardigen (Piotr Stępniak)
- Boreal Genomics (Andre Marziali)
- Broad Institute (Niall Lennon)
- CellMax Life (Atul Sharan)
- Congenica (Nick Lench)
- DNAnexus (Brady Davis)
- Edico Genome (Rebecca Hemenway)
- Flatiron (Vineeta Agarwala)
- Foundation Medicine (Gaurav Singal)
- Genomenon (Mark Kiel)
- Genomic Health (Phil Febbo)
- Guardant Health (Daniel Simon)
- iNDx Technology (Shruti Krishna Desai)
- Inflammatix (Tim Sweeney)
- Johns Hopkins (Aalok Shah)
- Median Technologies (Johan Brag)
- Molecular Stethoscope (Mike Nerenberg)
- MUSC (Lewis Frey)
- N-of-One (Chris Cournoyer)
- Natera (Bernhard Zimmermann)
- Stanford University (Max Diehn)
- Sunquest
- Sutter Health (Walter Stewart)
- Thermo Fisher Scientific (James Godsey)
- Two Pore Guys (Trevor Morin)
- UCSF (Sharat Israni)
- Veracyte (Giulia C. Kennedy)
- Vitatex Inc. (Wen-Tien Chen)
Microbiome, CRISPR & Company Competition
- Abreos Biosciences (Bradley Messmer)
- BioCollective (Raul Cano)
- Caribou Biosciences (Rachel Haurwitz)
- CRISPR Therapeutics (Bill Landberg)
- DayTwo (Josh Stevens)
- Demala (Lada Rasochova)
- EpiBiome (Nick Conley)
- Genetic Foresight (Douglas Hapeman)
- Girihelt (Ravi Sachidanandam)
- InnoGenomics Technologies (Sudhir Sinha)
- Max Planck Inst. (Emmanuelle Charpentier)
- NeRx Biosciences (Robert Feltgen)
- Oxford Genetics
- Precision Biosciences (Matt Kane)
- Precyte (Robert Lipshutz)
- Root Deep Insight (Nathan Pearson)
- Second Genome (Glenn Nedwi)
- Siolta Therapeutics (Nikole Kimes)
- Synthego (Richard Stoner)
- Viome (Helen Messier)
The startup world is changing! Startups in “hard sciences” like biology or chemistry are now getting the attention they deserve from big investors and Fortune 500 companies.
PMWC 2018 Company Showcases
This is an exciting time to work in the fast-paced, innovative world of startups. Inventive approaches that challenge the traditional path to drug discovery, clinical trial patient selection, diagnostics, biomarker identification, disease understanding, big data analysis, instruments development, and more are truly disrupting healthcare.
At the upcoming PMWC 2018 Silicon Valley conference, January 22-24, 2018, we are adding a 5th Track for the first time in order to accommodate THREE dedicated tracks showcasing these innovative companies. You’ll hear their impressive stories, including their most recent developments and see how they’re changing healthcare to achieve better outcomes, reduce costs, expedite disease identification, improve patient treatment and prevent disease.
150+ up and coming companies working in Artificial Intelligence, Immunotherapy, Liquid Biopsy, Data Applications in Clinical Dx, NGS Data, CRISPR and the Microbiome will be presenting. Find the growing list at the end of this email and in the program. In addition, we’ll feature a session on the challenges and opportunities of Blockchain in Precision Medicine.
PMWC 2018 Company Competition
In addition to the three Company Showcase tracks, we provide the Company Competition as an opportunity for emerging companies to be spotlighted and noticed by VCs.
Past winners in the Company Competition span a wide variety of platforms and applications including diagnostics, genome editing, NI IVF test, Rx/Dx development, and digital PCR.
Submit your own company to get the opportunity to present or nominate another promising early-stage company to participate in this prestigious competition and vie for the top award. This event guarantees the much coveted exposure and recognition required to reach the next level.
Exhibit
PMWC 2018 Silicon Valley offers exhibition opportunities for emerging and established companies and organizations to showcase their products and services to PMWC participants who are actively involved in and leading the personalized medicine revolution. See who is exhibiting here. If you are interested in exhibiting this year, contact us today as we are 90% booked.
List of Showcase Companies and Company Competition Contestants:
Artificial Intelligence
- AiCure (Adam Hanina)
- All4Cure (Tony Blau)
- Altoida (Ioannis Tarnanas)
- Arterys (Fabien Beckers)
- Atomwise (Abraham Heifets)
- Ayasdi (Bob Griffin)
- Bay Labs (Charles Cadieu)
- Berg Analytics (Slava Akmaev)
- Biodesix (Heinrich Roder)
- Carta Healthcare (David Scheinker)
- Cofactor Genomics (Jarret Glasscock)
- Cognoa (Sharief Taraman)
- CureMetrix (Kevin Harris)
- Data Collective (Scott Barclay)
- doc.ai (Walter De Brouwer)
- DxTerity (Bob Terbrueggen)
- e-Therapeutics (Jonny Wray)
- Exscientia (Andrew Hopkins)
- Freenome (Gabe Otte)
- GNS Healthcare (Diane Wuest)
- Good AI Lab (Mohsen Hejrati)
- Healx (Tim Guilliams)
- InnVentis (Thomas Wilckens)
- Insilico Medicine (Alex Zhavoronkov)
- Lumiata (Ash Damle)
- Lunit (Anthony Paek)
- Mediimsight (Javier Gonzalez-Zabaleta)
- Mendel.ai (Karim Galil)
- Molecular Health
- NuMedii (Asim Siddiqui)
- Numerate (Guido Lanza)
- Oxford University
- Owkin (Thomas Clozel)
- PathAi (Andrew Beck)
- Pathway Genomics (Michael Nova)
- PhenoMX (Mark Punyanitya)
- Physiq (Gary Conkright)
- quibim (Angel Alberich-Bayarri)
- Recursion Pharma (Ron Alfa)
- Sema4 (Eric Schadt)
- SkinVision (Erik de Heus)
- Sophia Genetics (Jurgi Camblong)
- SRI (David Sahner)
- Standigm (Sang Ok Song)
- Suggestic (Victor Chapela)
- Tempus (Eric Lefkofsky)
- twoXAR (Andrew Radin)
- UCSF (John Shephard)
- USC (Dan Ruderman)
- Verily (Jessica Mega)
- Zogenix (Anupam Agarwal)
Immunotherapy
- Abpro (Gavin MacBeath)
- Adaptimmune (Rafael Amado)
- Adicet Bio (Aya Jackovits)
- Bavarian Nordic (Christopher Heery)
- BeiGene (Amy Peterson)
- CellSight Technology (Aruna Gambhir)
- Compugen (John Hunter)
- Five Prime (Rusty Williams)
- Genentech (Ira Mellman)
- Genocea Biosciences (Jessica Baker Flechtner)
- Gristone Oncology (Roman Yelensky)
- Heat Biologics (Jeffrey Hutchins)
- Idera Pharmaceuticals (Joanna Horobin)
- Immix (Ilya Michael Rachman)
- Immune Design (Sergey Yurasov)
- Immune Systems Key (Yoram Devary)
- ImmunGene (Michael Gresser)
- Imperial College (Justin Stebbing)
- Incyte (Susan Snodgrass)
- MacroGenics (Jon Wigginton)
- Massachusetts General Hospital (Mark Cobbold)
- Medigene AG (Dolores Schendel)
- Mitra Biotech (Parker Cassidy)
- NanoString (Alessandra Cesano)
- NantKwest (David Pyrce)
- Neon (Richard Gaynor)
- Olink Proteomics (Jon Heimer)
- Onco Response (Kristine Swiderek)
- Oncorus (Mitchell Finer)
- Parker Inst. (Jeff Bluestone)
- Precision Oncology (Patricia Devitt Risse)
- Stanford Healthcare (Ron Levy)
- UCSC (Daniel Kim)
- Xcell Biosciences (Brian Feth)
Liquid Biopsy, Data App in Clinical Dx & NGS Data
- Accuragen (Li Weng)
- Angle PLC
- Ardigen (Piotr Stępniak)
- Boreal Genomics (Andre Marziali)
- Broad Institute (Niall Lennon)
- CellMax Life (Atul Sharan)
- Congenica (Nick Lench)
- DNAnexus (Brady Davis)
- Edico Genome (Rebecca Hemenway)
- Flatiron (Vineeta Agarwala)
- Foundation Medicine (Gaurav Singal)
- Genomenon (Mark Kiel)
- Genomic Health (Phil Febbo)
- Guardant Health (Daniel Simon)
- iNDx Technology (Shruti Krishna Desai)
- Inflammatix (Tim Sweeney)
- Johns Hopkins (Aalok Shah)
- Median Technologies (Johan Brag)
- Molecular Stethoscope (Mike Nerenberg)
- MUSC (Lewis Frey)
- N-of-One (Chris Cournoyer)
- Natera (Bernhard Zimmermann)
- Stanford University (Max Diehn)
- Sunquest
- Sutter Health (Walter Stewart)
- Thermo Fisher Scientific (James Godsey)
- Two Pore Guys (Trevor Morin)
- UCSF (Sharat Israni)
- Veracyte (Giulia C. Kennedy)
- Vitatex Inc. (Wen-Tien Chen)
- Abreos Biosciences (Bradley Messmer)
- BioCollective (Raul Cano)
- Caribou Biosciences (Rachel Haurwitz)
- CRISPR Therapeutics (Bill Landberg)
- DayTwo (Josh Stevens)
- Demala (Lada Rasochova)
- EpiBiome (Nick Conley)
- Genetic Foresight (Douglas Hapeman)
- Girihelt (Ravi Sachidanandam)
- InnoGenomics Technologies (Sudhir Sinha)
- Max Planck Inst. (Emmanuelle Charpentier)
- NeRx Biosciences (Robert Feltgen)
- Oxford Genetics
- Precision Biosciences (Matt Kane)
- Precyte (Robert Lipshutz)
- Root Deep Insight (Nathan Pearson)
- Second Genome (Glenn Nedwi)
- Siolta Therapeutics (Nikole Kimes)
- Synthego (Richard Stoner)
- Viome (Helen Messier)
RECENTLY ADDED ADDITIONAL PMWC 2018 SHOWCASES:
• Clinical-grade Testing Showcase
• NGS Instruments/Consumables Showcase
• Wellness & Aging Showcase
EMAIL [email protected] IF YOU’D LIKE TO APPLY TO PRESENT.
We are truly excited to have these healthcare disruptors joining us at PMWC 2018 Silicon Valley.
See a full list of the PMWC’s confirmed sessions – 45 and counting – here.
The Precision Medicine World Conference (PMWC), in its 17th installment, will take place in the Santa Clara Convention Center (Silicon Valley) on January 21-24, 2020. The program will traverse innovative technologies, thriving initiatives, and clinical case studies that enable the translation of precision medicine into direct improvements in health care. Conference attendees will have an opportunity to learn first-hand about the latest developments and advancements in precision medicine and cutting-edge new strategies and solutions that are changing how patients are treated.
See 2019 Agenda highlights:
- Five tracks will showcase sessions on the latest advancements in precision medicine which include, but are not limited to:
- AI & Data Science Showcase
- Clinical & Research Tools Showcase
- Clinical Dx Showcase
- Creating Clinical Value with Liquid Biopsy ctDNA, etc.
- Digital Health/Health and Wellness
- Digital Phenotyping
- Diversity in Precision Medicine
- Drug Development (PPPs)
- Early Days of Life Sequencing
- Emerging Technologies in PM
- Emerging Therapeutic Showcase
- FDA Efforts to Accelerate PM
- Gene Editing
- Genomic Profiling Showcase
- Immunotherapy Sessions & Showcase
- Implementation into Health Care Delivery
- Large Scale Bio-data Resources to Support Drug Development (PPPs)
- Microbial Profiling Showcase
- Microbiome
- Neoantigens
- Next-Gen. Workforce of PM
- Non-Clinical Services Showcase
- Pharmacogenomics
- Point-of Care Dx Platform
- Precision Public Health
- Rare Disease Diagnosis
- Resilience
- Robust Clinical Decision Support Tools
- Wellness and Aging Showcase
See 2019 Agenda highlights:
- Five tracks will showcase sessions on the latest advancements in precision medicine which include, but are not limited to:
- AI & Data Science Showcase
- Clinical & Research Tools Showcase
- Clinical Dx Showcase
- Creating Clinical Value with Liquid Biopsy ctDNA, etc.
- Digital Health/Health and Wellness
- Digital Phenotyping
- Diversity in Precision Medicine
- Drug Development (PPPs)
- Early Days of Life Sequencing
- Emerging Technologies in PM
- Emerging Therapeutic Showcase
- FDA Efforts to Accelerate PM
- Gene Editing / CRISPR
- Genomic Profiling Showcase
- Immunotherapy Sessions & Showcase
- Implementation into Health Care Delivery
- Large Scale Bio-data Resources to Support Drug Development (PPPs)
- Microbial Profiling Showcase
- Microbiome
- Neoantigens
- Next-Gen. Workforce of PM
- Non-Clinical Services Showcase
- Pharmacogenomics
- Point-of Care Dx Platform
- Precision Public Health
- Rare Disease Diagnosis
- Resilience
- Robust Clinical Decision Support Tools
- Wellness and Aging Showcase
- A lineup of 450+ highly regarded speakers featuring pioneering researchers and authorities across the healthcare and biotechnology sectors
- Luminary and Pioneer Awards, honoring individuals who contributed, and continue to contribute, to the field of Precision Medicine
- 2000+ multidisciplinary attendees, from across the entire spectrum of healthcare, representing different types of companies, technologies, and medical centers with leadership roles in precision medicine
